Inventor · disambiguated record
Michael George Hunter
Also filed as: HUNTER MICHAEL · HUNTER MICHAEL G · HUNTER MICHAEL GEORGE
22 granted patents·3 pending applications·281 citations·filing 1990–2012
96Inventor score
Files withBRITISH BIOTECH PHARM13MIDDLEMISS DAVID4BRITISH BIO TECHNOLOGY2OXAGEN LTD2BRITISH BIOTECH1
Top patents by PatentIndex Score
25 records- 0191US7582672B2Compounds for the treatment of CRTH2-mediated diseases and conditionsOXAGEN LTD·Filed 2004·Granted Sep 1, 2009·32 cites·8 claims
- 0287US6057123AStem cell inhibiting proteinsBRITISH BIOTECH PHARM·Filed 1992·Granted May 2, 2000·66 cites·23 claims
- 0386US8198314B2Treatment of CRTH2-mediated diseases and conditionsMIDDLEMISS DAVID·Filed 2008·Granted Jun 12, 2012·7 cites·17 claims
- 0485US8314257B2Treatment of CRTH2-mediated diseases and conditionsMIDDLEMISS DAVID·Filed 2008·Granted Nov 20, 2012·6 cites·27 claims
- 0585US8163936B2Treatment of CRTH2-mediated diseases and conditionsMIDDLEMISS DAVID·Filed 2008·Granted Apr 24, 2012·6 cites·11 claims
- 0685US8163931B2Treatment of CRTH2-mediated diseases and conditionsMIDDLEMISS DAVID·Filed 2008·Granted Apr 24, 2012·6 cites·19 claims
- 0782US5434073AFibrinolytic and anti-thrombotic cleavable dimersBRITISH BIO TECHNOLOGY·Filed 1990·Granted Jul 18, 1995·43 cites·1 claims
- 0880US6787522B2Antibacterial agentsBRITISH BIOTECH PHARM·Filed 2002·Granted Sep 7, 2004·11 cites·17 claims
- 0974US7323448B2Antibacterial agentsBRITISH BIOTECH PHARM·Filed 2006·Granted Jan 29, 2008·1 cites·2 claims
- 1073US5856301AStem cell inhibiting proteinsBRITISH BIOTECH PHARM·Filed 1995·Granted Jan 5, 1999·21 cites·17 claims
- 1172US6545051B1Antibacterial hydroxamic acid derivativesBRITISH BIOTECH PHARM·Filed 2000·Granted Apr 8, 2003·3 cites·14 claims
- 1268US6423690B1Antibacterial agentsBRITISH BIOTECH PHARM·Filed 1999·Granted Jul 23, 2002·19 cites·36 claims
- 1364US7148198B2Antibacterial agentsBRITISH BIOTECH PHARM·Filed 2004·Granted Dec 12, 2006·1 cites·4 claims
- 1460US6908911B1Antibacterial agentsBRITISH BIOTECH PHARM·Filed 1999·Granted Jun 21, 2005·8 cites·2 claims
- 1558US6441042B1Hydroxamic acid derivatives as antibacterialsBRITISH BIOTECH PHARM·Filed 1999·Granted Aug 27, 2002·12 cites·16 claims
- 1655US7323563B2Hydroxamic acid derivatives as antibacterialsBRITISH BIOTECH PHARM·Filed 2005·Granted Jan 29, 2008·0 cites·8 claims
- 1755US5965697ADisaggregated mutant human RANTESBRITISH BIOTECH PHARM·Filed 1997·Granted Oct 12, 1999·16 cites·4 claims
- 1852US5925568ARelease and mobilization of haematopoietic cellsBRITISH BIOTECH PHARM·Filed 1994·Granted Jul 20, 1999·10 cites·10 claims
- 1951US6992190B2Hydroxamic acid derivatives as antibacterialsBRITISH BIOTECH PHARM·Filed 2002·Granted Jan 31, 2006·0 cites·7 claims
- 2041US5688664AThrombin activatable plasminogen analoguesBRITISH BIO TECHNOLOGY·Filed 1993·Granted Nov 18, 1997·4 cites·22 claims
- 2140US6881828B2Fusion proteins between antigenic amino acid sequences and beta-2-microglobulinISIS INNOVATIONS LTD·Filed 1994·Granted Apr 19, 2005·9 cites·24 claims
- 2239US2011124683A1Use of CRTH2 Antagonist CompoundsOXAGEN LTD·Filed 2010·Application pending·0 cites
- 2339US2004131598A1Cancer therapyFiled 2001·Application pending·0 cites
- 2435US2013052190A1CRTH2 Antagonists for Treatment of Eosinophilic Diseases and ConditionsPEARCE COLLINS LISA·Filed 2012·Application pending·0 cites
- 2519US6476067B1N-formyl hydroxylamine derivatives as antibacterial agentsBRITISH BIOTECH·Filed 1999·Granted Nov 5, 2002·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →